DK3452040T3 - Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler - Google Patents

Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler Download PDF

Info

Publication number
DK3452040T3
DK3452040T3 DK17793154.0T DK17793154T DK3452040T3 DK 3452040 T3 DK3452040 T3 DK 3452040T3 DK 17793154 T DK17793154 T DK 17793154T DK 3452040 T3 DK3452040 T3 DK 3452040T3
Authority
DK
Denmark
Prior art keywords
hydroxypyridonate
decorporating
actinide
lanthanide
treatments
Prior art date
Application number
DK17793154.0T
Other languages
English (en)
Inventor
Rebecca J Abergel
Gauthier J P Deblonde
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK3452040T3 publication Critical patent/DK3452040T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK17793154.0T 2016-05-03 2017-05-02 Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler DK3452040T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662331369P 2016-05-03 2016-05-03
US201662383963P 2016-09-06 2016-09-06
PCT/US2017/030628 WO2017192581A1 (en) 2016-05-03 2017-05-02 Formulations and treatments employing hydroxypyridonate actinide/lanthanide decorporation agents

Publications (1)

Publication Number Publication Date
DK3452040T3 true DK3452040T3 (da) 2024-05-21

Family

ID=60203422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17793154.0T DK3452040T3 (da) 2016-05-03 2017-05-02 Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler

Country Status (6)

Country Link
US (1) US20190183868A1 (da)
EP (2) EP3452040B1 (da)
JP (2) JP2019514944A (da)
CA (1) CA3022852A1 (da)
DK (1) DK3452040T3 (da)
WO (1) WO2017192581A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10982136B2 (en) 2016-02-26 2021-04-20 The Regents Of The University Of California Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters
US11235076B2 (en) 2016-08-29 2022-02-01 Fred Hutchinson Cancer Research Center Chelating platform for delivery of radionuclides
CA3035966A1 (en) 2016-09-06 2018-03-15 The Regents Of The University Of California Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
EP3520117B1 (en) 2016-09-29 2023-11-08 The Regents of The University of California Separation of metal ions by liquid-liquid extraction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846915B2 (en) * 2001-08-13 2005-01-25 The Regents Of The University Of California Hydroxypyridonate and hydroxypyrimidinone chelating agents
US8217173B2 (en) * 2007-02-13 2012-07-10 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Fluoride-releasing compositions
US20110250138A1 (en) * 2007-08-01 2011-10-13 Alnylam Pharmaceuticals, Inc. Single-stranded and double-stranded oligonucleotides comprising a metal-chelating ligand
WO2010129962A2 (en) * 2009-05-08 2010-11-11 The Regents Of The University Of California Combination treatment of hydroxypyridonate actinide/lanthanide decorporation agents
AU2014232416B2 (en) * 2013-03-15 2017-09-28 Xencor, Inc. Modulation of T Cells with Bispecific Antibodies and FC Fusions

Also Published As

Publication number Publication date
US20190183868A1 (en) 2019-06-20
EP3452040B1 (en) 2024-04-03
EP3452040A4 (en) 2019-12-25
JP2019514944A (ja) 2019-06-06
JP2023041952A (ja) 2023-03-24
EP4393548A2 (en) 2024-07-03
WO2017192581A1 (en) 2017-11-09
EP3452040A1 (en) 2019-03-13
CA3022852A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
DK3411398T3 (da) Målrettede terapeutiske midler og anvendelse heraf
DK3142637T3 (da) Keratin treatment formulations and methods
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
DK3505519T3 (da) Pyridinamin-substituerede heterotricyclo-forbindelser, fremstilling deraf og anvendelse i medicin
DK3307707T3 (da) Halogensubstituerede phenoxyphenylamidiner og anvendelsen deraf som fungicider
DK3177640T3 (da) Pd-1-midler med høj affinitet og anvendelsesfremgangsmåder
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3492455T3 (da) 1,2,4-triazoler som nukleare transportmodulatorer og anvendelse til behandling af specifikke former for cancer
MA42844A (fr) Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1
DK3143011T3 (da) Deutererede heterocykliske forbindelser og deres anvendelse som billeddannende stoffer
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3256598T3 (da) Svampestammer og anvendelsesfremgangsmåder
DK3268374T3 (da) Kv1.3-inhibitorer og deres medicinske anvendelse
DK3420039T3 (da) Printningsformuleringer og fremgangsmåder
DK3558260T3 (da) Kosmetisk sammensætning omfattende et chaga-ekstrakt og anvendelse deraf
DK3288825T3 (da) Teleskopisk adgangsbro, enhed forsynet hermed og tilhørende fremgangsmåde
DK3452040T3 (da) Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler
DK3326463T3 (da) Midesammensætning og anvendelse deraf som biologisk bekæmpelsesmiddel
DK3156181T3 (da) Sikkerhedsindretning og værktøj
FR3020946B1 (fr) Nouvelles preparations cosmetiques et/ou dermatologiques extemporanees
DK3490988T3 (da) Ny forbindelse og fremgangsmåde
DK3491345T3 (da) Pumpehoved og doseringsenhed
DK3383872T3 (da) 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin